Dividend Intimation-Corporate Action for final dividend for the year ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Coral Laboratories Ltd has informed BSE that its Board of Directors will meet on May 30, 2025 to consider and approve standalone audited financial results for Q4 and the full financial year ended March 31, 2025. The Board will also consider recommending a final dividend on equity shares for FY 2024-25, though the amount is not yet decided and the word 'if any' suggests it may or may not be declared. Additionally, the Board will appoint the Secretarial Auditor for five years starting FY 2025-26, and appoint Internal and Cost Auditors for FY 2025-26. The trading window for insiders has been closed since April 1, 2025 and will reopen 48 hours after results are declared.
This is a procedural advance notice, not an actual dividend declaration. Shareholders should wait for the May 30 board meeting outcome to know the final dividend amount and FY25 results. Any dividend will only benefit shareholders recorded on the book closure date announced later.